Minimally invasive transforaminal lumbar interbody fusion for spondylolisthesis:reduction fusion vs.in-situ fusion

Guo-xin FAN,Dong-dong WANG,Xin-bo WU,Yan-jie ZHU,Xiao-fei GUAN,Guang-fei GU,Xin GU,Hai-long ZHANG,Shi-sheng HE
DOI: https://doi.org/10.3969/j.issn.1672-2957.2016.06.004
2016-01-01
Abstract:Objective To investigate the long term results of minimally invasive transforaminal lumbar interbody fusion (MIS-TLIF) with reduction fusionversus in-situ fusion for spondylolisthesis. Methods The clinical data of 62 patients from January 2010 to April 2013 was analyzed retrospectively,including 27 meales and 35 females with a mean age of 55.3±13.3 years. Inclusion criteria:Meyerding gradeⅠand Ⅱ single segmental spondylolisthesis;underwent MIS-TLIF’s reduction fusion(35 cases) or in-situ(27 cases) fusion;followed up for >30 months. Hospital stay,operation time,blood loss, complication,and the visual analogue scale(VAS) score,Oswestry disability index(ODI) and Japanese Orthopaedic Association(JOA) score at pre-operation,postoperative 3 months and final follow-up were compared between the 2 groups. Patient satisfaction with the therapeutic eficacy was evaluated with modified MacNab criteria,and Bridwell criteria was used to assess the fusion condition. Results There was no significant difference in the hospital stay,operation time,blood loss, complications,satisfaction,fusion condition between the 2 groups(P>0.05). There was also no significant difference in the VAS score,ODI,JOA score at pre-operation,postoperative 3 months and final follow-up between the 2 groups(P>0.05). Conclusion There is no significant difference in MIS-TLIF for lumbar spondylolisthesis between reduction fusion and in-situ fusion.
What problem does this paper attempt to address?